Ossianix is one to watch, BearDownAZ, but they do use the transferrin receptor so that could be a limiting factor compared to Transcend. They also report that delivered therapeutics are "long lasting" at 72 hours. We've shown that Transcend (MTfp) does not affect the half life of delivered therapeutics. It sounds like Ossianix doesn't apprear to be able to say that. biOasis has reported delivered therapeutics lasting up to 14 days, if my memory serves me well, although half life is goverened by the therapeutic, not by Transcend.

It wouldn't surprise me to see Lundbeck and biOasis in the same sentence at some point.

jdstox